Certain blood thinners can cause tinnitus, but the relationship depends heavily on which medication you’re taking and at what dose. Aspirin, a drug most people think of as a simple painkiller rather than a blood thinner, is the best-documented culprit. Prescription anticoagulants like warfarin and the newer direct oral anticoagulants have a murkier connection to ringing in the ears, one that may have more to do with the underlying conditions they treat than the drugs themselves.
Aspirin Is the Clearest Link
When people ask whether blood thinners cause tinnitus, the answer that has the strongest scientific backing involves aspirin, technically classified as an antiplatelet agent. At low “cardiac” doses (75 to 100 mg daily), aspirin rarely causes noticeable ear symptoms. The trouble starts at higher doses, the kind sometimes used for pain relief or inflammation, generally above 2 to 3 grams per day. At those levels, tinnitus is a well-recognized side effect, and it has been studied in detail for decades.
The mechanism is surprisingly specific. Aspirin belongs to the salicylate family, and salicylates interfere with the function of outer hair cells in the cochlea. These hair cells are responsible for amplifying sound signals before they reach the brain. Salicylate molecules displace chloride ions from binding sites on a motor protein called prestin, which sits in the outer hair cell membrane and drives the cell’s ability to change shape in response to sound.1PubMed Central. Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology When prestin can’t do its job, cochlear amplification weakens. That reduced signal appears to trigger compensatory changes in the brain that produce the perception of ringing or buzzing.
Laboratory studies have shown that these changes are dose-dependent and reversible. When salicylate was applied directly to isolated outer hair cells, the internal structures of the cells swelled and shifted out of alignment, and electromotility (the cell’s ability to vibrate) was blocked. Once the salicylate was washed away, both the structural changes and the motility recovered over about 30 minutes.2PubMed. Concomitant salicylate-induced alterations of outer hair cell subsurface cisternae and electromotility This reversibility is encouraging: aspirin-induced tinnitus typically fades within a day or two of stopping the drug or lowering the dose. Permanent damage is rare at commonly used levels, though prolonged high-dose use raises the risk.
What Happens in the Brain After the Cochlea Is Affected
The outer hair cell disruption from salicylates or other ototoxic drugs is only the starting point. Tinnitus isn’t generated entirely in the ear; much of it is a brain phenomenon. When cochlear signals weaken, the central auditory pathway compensates by turning up its own gain, amplifying whatever neural activity it receives. Research into drug-induced ototoxicity has shown that as weakened cochlear signals travel upward through the auditory system, they get progressively amplified until the neural responses in the auditory cortex become much larger than normal.3PubMed Central. Neural Mechanisms of Tinnitus and Hyperacusis in Acute Drug-Induced Ototoxicity This excessive central gain, likely driven by reduced inhibition in the auditory brain regions, is now considered a major contributor to both tinnitus and hyperacusis (an abnormal sensitivity to everyday sounds).
This is why tinnitus can persist even after the direct cochlear insult has resolved. The brain, having adapted to reduced input, doesn’t always revert instantly. In most cases of short-term aspirin use, the neural recalibration is temporary. But in people who already have some degree of hearing loss or who take ototoxic medications over long periods, the central gain adjustment can become more entrenched.
Prescription Anticoagulants and Tinnitus
Warfarin, heparin, and the direct oral anticoagulants (apixaban, rivaroxaban, dabigatran, edoxaban) work differently from aspirin. They target clotting factors rather than platelets. Their connection to tinnitus is less straightforward and less well studied.
There is no established mechanism by which warfarin or the DOACs directly damage hair cells in the way salicylates do. Tinnitus is listed as a possible side effect in the prescribing information for some of these drugs, but post-marketing side-effect reports are notoriously unreliable for establishing cause and effect. Someone who starts warfarin for atrial fibrillation, for example, is typically older, may already have cardiovascular risk factors that affect inner ear blood flow, and is often taking multiple medications. Teasing out whether the anticoagulant itself caused new tinnitus is genuinely difficult.
One area of concern is intracochlear hemorrhage. The inner ear has a tiny, delicate blood supply, and anticoagulants by definition make bleeding easier. A study examining sudden sensorineural hearing loss in patients on oral anticoagulant therapy found ten cases, with some patients showing prolonged coagulation values at the time the hearing loss appeared. However, the researchers were unable to establish a definitive link between the anticoagulation and the hearing loss.4PubMed. Sudden sensorineural hearing loss during oral anticoagulant therapy The inner ear is so small that even minor bleeding could theoretically disrupt function, but proving this is happening in a given patient is another matter entirely.
Why the Inner Ear Is So Vulnerable
To understand why blood-related medications might affect hearing at all, it helps to know how unusual the inner ear’s blood supply is. The cochlea receives an extraordinarily small fraction of total blood flow, estimated at roughly one millionth of cardiac output in humans.5PubMed Central. Physiopathology of the Cochlear Microcirculation The sensory hair cells have almost no tolerance for oxygen deprivation. Any disruption to that tiny blood supply, whether from a clot, a bleed, or changes in blood flow characteristics caused by medications, can affect hearing rapidly.
The stria vascularis, a highly vascularized tissue that lines part of the cochlea, maintains the electrochemical environment hair cells need to function. Damage to the vascular barrier in this structure leads to loss of the endocochlear potential, essentially the battery that powers hearing.5PubMed Central. Physiopathology of the Cochlear Microcirculation This fragile setup means the cochlea is affected by both too little blood flow and too much disruption of the vascular barrier. It is a system with almost no margin.
Pulsatile Tinnitus Is a Different Problem Entirely
Not all tinnitus is the same, and if you’re on blood thinners and notice a rhythmic whooshing or thumping in one ear, that’s a distinct condition called pulsatile tinnitus. Unlike the steady ringing of sensorineural tinnitus, pulsatile tinnitus usually has a vascular cause: you’re hearing actual blood flow near the ear, amplified by an abnormality in a nearby blood vessel.
Pulsatile tinnitus can be venous or arterial in origin. Venous pulsatile tinnitus tends to produce a lower-pitched whooshing sound that can sometimes be relieved by turning the head or pressing on the neck over the jugular vein on the affected side.6Journal of NeuroInterventional Surgery. Management of vascular causes of pulsatile tinnitus Arterial causes tend to sound higher-pitched and are not relieved by neck maneuvers. This distinction matters because the workup and treatment differ significantly.
One serious vascular cause is a dural arteriovenous fistula, an abnormal connection between an artery and a vein in the membranes surrounding the brain. In a review of 220 patients diagnosed with this condition over about a decade, roughly 14% initially presented with pulsatile tinnitus as their only symptom. The transverse-sigmoid sinus junction, located just behind the ear, was the most common site. When the fistula was treated with embolization, the pulsatile tinnitus disappeared completely in about 81% of patients and improved markedly in another 12%.7Nature. Dural arteriovenous fistula masquerading as pulsatile tinnitus: radiologic assessment and clinical implications
Blood thinners don’t cause these structural vascular problems. But if you develop pulsatile tinnitus while on an anticoagulant, the medication could theoretically alter the sound’s intensity or character by changing blood flow dynamics. More importantly, pulsatile tinnitus deserves imaging to rule out a treatable vascular abnormality, regardless of what medications you’re taking.
When Blood Thinners Actually Treat Tinnitus
Here’s where the picture gets counterintuitive. In some cases, anticoagulants have been used as treatment for tinnitus rather than being a cause of it. When pulsatile tinnitus results from venous stenosis (narrowing of a vein near the ear), anticoagulation can improve flow through the affected vessel and reduce or eliminate the sound.
A published case report described a patient with pulsatile tinnitus caused by internal jugular vein stenosis who was treated with apixaban. Over 12 months, with the dose gradually tapered, the patient’s symptoms improved progressively and eventually resolved completely. Follow-up imaging confirmed improved blood flow through the jugular venous system.8PubMed Central. Anticoagulation in the Treatment of Pulsatile Tinnitus Caused by Internal Jugular Vein Stenosis: A Rare Case Report This is a single case, not a basis for general treatment recommendations, but it illustrates that the relationship between blood thinners and tinnitus runs in both directions depending on what’s causing the tinnitus in the first place.
Other Medications That Raise the Risk
Most people taking blood thinners are also taking other medications, and several of those carry their own tinnitus or hearing loss risk. Ototoxicity, meaning drug-related damage to the hearing or balance system, can present as tinnitus, hearing loss, a feeling of ear fullness, or dizziness.9PubMed Central. Ototoxicity: A Challenge in Diagnosis and Treatment When someone on a blood thinner develops tinnitus, it’s worth asking whether one of their other medications is contributing.
Diuretics, commonly prescribed alongside blood thinners for conditions like heart failure and hypertension, are among the more frequently implicated drugs. A prospective study of patients with high blood pressure found that those taking diuretics had tinnitus at roughly twice the rate of those on some other drug classes. About 27% of diuretic users in the study reported tinnitus, compared to around 12 to 14% of patients taking angiotensin receptor blockers or statins.10PubMed Central. Prevalence of tinnitus in patients with hypertension and the impact of different antihypertensive drugs on the incidence of tinnitus Loop diuretics specifically, such as furosemide, are well-known ototoxic agents at higher doses.
NSAIDs deserve particular mention because many people take them casually alongside prescribed blood thinners. Both aspirin and non-aspirin NSAIDs like ibuprofen can affect cochlear function, and they also interact with anticoagulants to increase bleeding risk. The combination is doubly relevant to the ears: the NSAID may affect hearing directly while also changing the effective anticoagulation level.
Aging, Hearing Loss, and Medication Burden
The typical blood thinner patient is not young. Atrial fibrillation, deep vein thrombosis, and mechanical heart valves skew older, meaning most anticoagulant users already face age-related hearing decline. This overlap makes it harder to tell whether new tinnitus comes from the medication, from the underlying vascular disease, or simply from the natural progression of hearing loss.
A large longitudinal study found that the number of ototoxic medications a person takes independently predicts the risk of developing hearing loss over ten years, even after accounting for age, sex, smoking, and body weight. Each additional ototoxic medication increased that risk by about 15%. Loop diuretics and NSAIDs specifically were both associated with a meaningfully higher rate of progressive hearing loss over the same period.11PubMed Central. The Contribution of Ototoxic Medications to Hearing Loss Among Older Adults The study focused on older adults, the population most likely to be on anticoagulants, which means their medication burden is doing real, measurable damage to hearing in the aggregate.
This doesn’t mean you should stop taking necessary medications. But it does mean that if you’re on a blood thinner plus a diuretic plus an occasional NSAID and you notice tinnitus, the culprit might not be any single drug. It may be the cumulative load on a cochlea that was already becoming more fragile with age.
The Nocebo Effect and Tinnitus Perception
There is an aspect of this question that rarely gets discussed: expectation itself can create or intensify side effects. When someone reads that a medication may cause tinnitus and then starts paying close attention to their ears, they sometimes begin perceiving sounds they might otherwise have ignored. This is not “imaginary” tinnitus. The neural signal is real, but the awareness and distress around it can be shaped by prior expectations.
Research on the nocebo effect (the opposite of placebo, where expecting harm causes harm) has demonstrated that simply being told a substance causes certain symptoms significantly increases how many people report those symptoms. In one experimental study, about 70% of participants who received a pharmacologically inert substance reported side effects when they expected them. Importantly, giving people information about the nocebo effect itself reduced the number of symptoms they reported, with a moderate-to-large effect size.12PubMed Central. Minimizing Drug Adverse Events by Informing About the Nocebo Effect—An Experimental Study
This finding cuts both ways for tinnitus. On one hand, it suggests that some fraction of people who attribute their tinnitus to a new medication may be experiencing a nocebo response. On the other hand, dismissing all medication-related tinnitus as “just anxiety” would be irresponsible when drugs like aspirin have a proven ototoxic mechanism. The practical takeaway: if you notice tinnitus after starting a blood thinner, take it seriously enough to mention to your doctor, but know that heightened awareness of the symptom can itself amplify its perceived severity.
Ginkgo Biloba and Herbal Blood Thinners
Ginkgo biloba is one of the most commonly used herbal supplements for tinnitus, marketed on the premise that improving blood flow to the inner ear might reduce symptoms. At the same time, ginkgo has significant anticoagulant properties. It interferes with platelet aggregation and has been implicated in serious bleeding events, including intracranial hemorrhage, when taken alongside prescription blood thinners like warfarin, aspirin, or clopidogrel.
This creates a paradox. People with tinnitus who are already on anticoagulants may reach for ginkgo as a “natural” remedy, unknowingly stacking two blood-thinning effects. Clinical evidence for ginkgo’s effectiveness against tinnitus is weak; a Cochrane review found no convincing evidence that it works. Meanwhile, the bleeding risk is real. Anyone taking a prescription anticoagulant or antiplatelet drug should avoid ginkgo unless their doctor has specifically approved the combination, and anyone scheduled for surgery should stop it well in advance.
What You Should Do If You Notice Ringing
If tinnitus appears or worsens after starting a blood thinner, the first step is identifying whether the sound is continuous (a steady ring, hiss, or buzz) or pulsatile (rhythmic, matching your heartbeat). Pulsatile tinnitus warrants imaging because it can signal a treatable vascular problem, as discussed above with dural fistulas and venous stenosis.
For continuous tinnitus, the timeline and dose matter. If you recently increased your aspirin dose and developed ringing, the connection is likely real and reversible. If you’ve been on a stable dose of apixaban for a year and the tinnitus appeared gradually, your anticoagulant is a less probable culprit, and other medications or age-related changes are worth investigating. Review your full medication list with your doctor, paying special attention to diuretics, NSAIDs, and aminoglycoside antibiotics if you’ve had any recent infections treated intravenously.
Baseline audiometry, a formal hearing test, is useful for anyone on long-term ototoxic medications. It gives you and your doctor a reference point so that any future changes in hearing can be measured objectively rather than relying on your subjective sense of whether things are getting worse. Some clinical guidelines recommend serial monitoring for patients on known ototoxic drugs, though this is more consistently applied for high-risk medications like chemotherapy agents than for blood thinners.
Stopping a blood thinner on your own because of tinnitus carries risks that typically outweigh the annoyance of ringing ears. The conditions these medications treat, including stroke prevention in atrial fibrillation and treatment of blood clots, are serious. A conversation with your prescribing doctor is the right path, not an abrupt change in therapy.